AbCellera Biologics Inc. (ABCL)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in AbCellera Biologics Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If AbCellera Biologics Inc. (ABCL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies SAMSUNG ELECTR GDR REG S (SMSN) as the most exposed collateral stock, sharing 1 ETFs with ABCL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
ABCL Ownership Dynamics
ETFs with Highest ABCL Exposure
Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 84,559 | $4.77 | $403,346.43 |
| 2026-05-13 | 50,335 | $4.95 | $249,158.25 |
| 2026-05-12 | 108,660 | $5.25 | $570,465 |
| 2026-05-11 | 55,208 | $5.24 | $289,289.92 |
| 2026-05-08 | 17,974 | $4.82 | $86,634.68 |
| 2026-05-07 | 80,098 | $5.04 | $403,693.92 |
| 2026-05-06 | 376,377 | $4.66 | $1.8M |
| 2026-05-05 | 73,828 | $4.59 | $338,870.52 |
| 2026-05-04 | 25,166 | $4.43 | $111,485.38 |
| 2026-05-01 | 99,534 | $4.15 | $413,066.1 |
| 2026-04-30 | 286,808 | $3.82 | $1.1M |
| 2026-04-29 | 1,786,958 | $4.16 | $7.4M |
| 2026-04-28 | 619,362 | $4.16 | $2.6M |
| 2026-04-27 | 1,340 | $4.15 | $5,561 |
| 2026-04-24 | 889 | $4.05 | $3,600.45 |
| 2026-04-23 | 1,389 | $4.08 | $5,667.12 |
| 2026-04-22 | 2,606 | $3.99 | $10,397.94 |
| 2026-04-20 | 102,662 | $4.01 | $411,674.62 |
| 2026-04-17 | 7,219 | $3.83 | $27,648.77 |
| 2026-04-16 | 88,040 | $3.86 | $339,834.4 |
| 2026-04-15 | 18,237 | $3.76 | $68,571.12 |
| 2026-04-14 | 9,101 | $3.66 | $33,309.66 |
| 2026-04-13 | 9,293 | $3.54 | $32,897.22 |
| 2026-04-10 | 13 | $3.44 | $44.72 |
| 2026-04-09 | 337,223 | $3.43 | $1.2M |
| 2026-04-07 | 65,547 | $3.39 | $222,204.33 |
| 2026-04-06 | 91,930 | $3.52 | $323,593.6 |
| 2026-04-01 | 857 | $3.49 | $2,990.93 |
| 2026-03-31 | 5,948 | $3.28 | $19,509.44 |
| 2026-03-30 | 164,574 | $3.27 | $538,156.98 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare ABCL to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.